Medical News

RSS

Results from ICH compliant Phase II study of MRX-4 presented at EAACI Congress

Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London. The study's principal investigators were Drs. Eric Bateman, Mary Bateman and Paul Potter.

16 Jun 2010

U.S. State Department releases 2010 report on human trafficking

The U.S. State Department on Monday released its 2010 report on human trafficking, which "grades 175 nations on their efforts to fight this modern form of slavery," Bloomberg Businessweek reports (Kate/Gaouette, 6/15).

16 Jun 2010

UIC reports first successful robotic kidney transplant in morbidly obese patient

Surgeons at the University of Illinois at Chicago report the first successful robotic kidney transplant in a morbidly obese patient.

16 Jun 2010

Research investigates surgical outcomes of patients with NSCLC

Research published in the June edition of the Journal of Thoracic Oncology sought to investigate the time trends of surgical outcomes of patients with non-small cell lung cancer between 1979 and 2008. The incidence of lung cancer continues to rise; therefore, countermeasures to decrease death rates have become an important public health issue.

16 Jun 2010

New data shows Ohio children with special health care needs have inadequate insurance coverage

A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.

16 Jun 2010

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

16 Jun 2010

joimax moves into larger premises in Germany, US

The medical devices company joimax(R) GmbH is moving into new premises both in Germany and the US. "Growth requires space" had already been the motto of the last company move back in 2005.

16 Jun 2010

Florida State University researcher explores role of key protein in cell division

A Florida State University researcher has identified the important role that a key protein plays in cell division, and that discovery could lead to a greater understanding of stem cells.

16 Jun 2010

Global drug distribution programs one factor in hastening drug resistance, report says

A Center for Global Development (CGD) report released Tuesday details factors leading to increased drug resistance worldwide, including drug distribution programs in developing countries, Reuters reports.

16 Jun 2010

Newly published research examines association between CKD and CYP24

Cytochroma today announced the publication of new data from studies in a preclinical model indicating that chronic kidney disease is associated with markedly increased expression of the vitamin D catabolic enzyme, CYP24, which contributes to vitamin D insufficiency and resistance to vitamin D therapy. Parallel analysis of kidney biopsies obtained from CKD patients confirmed abnormal CYP24 expression in human disease as well.

16 Jun 2010

Elekta exercises share repurchase authorization

The Board of Directors of Elekta AB has decided to utilize the authorization received from the Annual General Meeting to repurchase shares in the company.

From Elekta 16 Jun 2010

Menicon announces acquisition of Lagado

Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.

16 Jun 2010

Ahead of International Development Association meeting, Reuters examines aid prospects for developing world

Reuters examines the challenges facing the World Bank as it tries to secure aid for the developing world while some of the wealthiest nations are "feeling pinched themselves."

16 Jun 2010

Study aims at determining optimal dose of nab-paclitaxel with carboplatin as first-line therapy for NSCLC

The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer. Results will provide researchers with a data needed to guide a phase 3 trial.

16 Jun 2010

Rating system for Medicare Advantage plans slated for upgrade

Writing for Kaiser Health News in collaboration with The Washington Post, Susan Jaffe reports: "For consumers looking for bargains on refrigerators or restaurants, ratings can be helpful. But a score card doesn't work as well for selecting a Medicare private health plan" (Jaffe, 6/15).

16 Jun 2010

Normal daily activity best for patients with low-back pain: Study

For much of the 20th century, "rest"— which generally meant a few days to a week in bed — was the standard prescription for acute low-back pain. In recent decades, however, doctors started counseling patients to stay as active as they could.

16 Jun 2010

European Commission grants Orphan Medicinal Product Designation for QPI-1002

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that the European Commission has granted Orphan Medicinal Product Designation for QPI-1002 (also referred to as "I5NP") for the prophylaxis of delayed graft function in kidney transplant patients.

16 Jun 2010

Disorder in degradation of proteins and other macromolecules in cells leads to serious diseases

The degradation of proteins and other macromolecules in cells is vital to survival. Disruption of this process can result in serious disease. The research group of Professor Thomas Jentsch (Leibniz Institute for Molecular Pharmacology, FMP/ Max Delbr-ck Center for Molecular Medicine, MDC, Berlin-Buch) has now succeeded in identifying an essential cellular process necessary for the transport and degradation of macromolecules in endosomes and lysosomes, respectively.

16 Jun 2010

ISB, GIND collaborate on whole-genome sequencing to identify drug targets for Huntington's Disease

The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets related to the onset and progression of Huntington's disease (HD). The research team, led by GIND associate director and senior investigator Steven Finkbeiner, MD, PhD, will also use induced pluripotent stem (iPS) cells from patients with HD to screen for drugs that might delay, prevent, or even reverse this devastating condition.

16 Jun 2010

Supreme Court to hear case on overcrowding and medical needs of Calif. prisoners; Ohio state employees have unusual situation covering adult children

Agreeing to hear an appeal from Gov. Arnold Schwarzenegger, the U.S. Supreme Court said Monday it will decide whether the state can be forced to release 46,000 inmates — more than one-fourth of its prison population — to relieve overcrowding. The justices said they would hear the case in the fall and rule early next year.

16 Jun 2010

Medical News

Results from ICH compliant Phase II study of MRX-4 presented at EAACI Congress

U.S. State Department releases 2010 report on human trafficking

UIC reports first successful robotic kidney transplant in morbidly obese patient

Research investigates surgical outcomes of patients with NSCLC

New data shows Ohio children with special health care needs have inadequate insurance coverage

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

joimax moves into larger premises in Germany, US

Florida State University researcher explores role of key protein in cell division

Global drug distribution programs one factor in hastening drug resistance, report says

Newly published research examines association between CKD and CYP24

Elekta exercises share repurchase authorization

Menicon announces acquisition of Lagado

Ahead of International Development Association meeting, Reuters examines aid prospects for developing world

Study aims at determining optimal dose of nab-paclitaxel with carboplatin as first-line therapy for NSCLC

Rating system for Medicare Advantage plans slated for upgrade

Normal daily activity best for patients with low-back pain: Study

European Commission grants Orphan Medicinal Product Designation for QPI-1002

Disorder in degradation of proteins and other macromolecules in cells leads to serious diseases

ISB, GIND collaborate on whole-genome sequencing to identify drug targets for Huntington's Disease

Supreme Court to hear case on overcrowding and medical needs of Calif. prisoners; Ohio state employees have unusual situation covering adult children

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News